Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Tic Toc

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Aug 16, 2023 1:41pm

126 Views

Post# 35591335

RE:Tic Toc

Legitimate points I think you should sell.

consultant99 wrote:
Ever get that feeling that something isn't right?

Almost 1 year ago we were looking at a possible Q4 2022 BTD and news on the vaccine initiative. What we gotten is three private placements.

Lots of shareholder optimism but despite Fast Track designation and what appears to be outstanding results the only arbitrator that counts, the FDA, has not bestowed BTD on the company's drug treatment.

I have heard of fashionably late but WTF is going on?
More profit taking by the those having invested via PPs?
Somebody knows something?

Management owes shareholders an explaination as to why BTD hasn't been attained. The Q2 Management notes had better start providing shareholders with more useful information.